nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Advisory Board
|
|
|
2011 |
31 |
5 |
p. A3- 1 p. |
artikel |
2 |
Masthead
|
|
|
2011 |
31 |
5 |
p. IFC- 1 p. |
artikel |
3 |
Paradigm Shift in the Role of Uric Acid in Acute Kidney Injury
|
Shimada, Michiko |
|
2011 |
31 |
5 |
p. 453-458 6 p. |
artikel |
4 |
Population Heterogeneity in the Genetic Control of Serum Urate
|
Merriman, Tony R. |
|
2011 |
31 |
5 |
p. 420-425 6 p. |
artikel |
5 |
Table of Contents
|
|
|
2011 |
31 |
5 |
p. A1-A2 nvt p. |
artikel |
6 |
The Epidemiology of Uric Acid and Fructose
|
Rho, Young Hee |
|
2011 |
31 |
5 |
p. 410-419 10 p. |
artikel |
7 |
The Rediscovery of Uric Acid in Cardiorenal Disease: Introduction
|
Johnson, Richard J. |
|
2011 |
31 |
5 |
p. 391-393 3 p. |
artikel |
8 |
Urate Transporters: An Evolving Field
|
Anzai, Naohiko |
|
2011 |
31 |
5 |
p. 400-409 10 p. |
artikel |
9 |
Uric Acid: A Danger Signal From the RNA World That May Have a Role in the Epidemic of Obesity, Metabolic Syndrome, and Cardiorenal Disease: Evolutionary Considerations
|
Johnson, Richard J. |
|
2011 |
31 |
5 |
p. 394-399 6 p. |
artikel |
10 |
Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem
|
Kang, Duk-Hee |
|
2011 |
31 |
5 |
p. 447-452 6 p. |
artikel |
11 |
Uric Acid and Fructose: Potential Biological Mechanisms
|
Lanaspa, Miguel A. |
|
2011 |
31 |
5 |
p. 426-432 7 p. |
artikel |
12 |
Uric Acid and Hypertension
|
Feig, Daniel I. |
|
2011 |
31 |
5 |
p. 441-446 6 p. |
artikel |
13 |
Uric Acid and Transplantation
|
Mazali, Fernanda Cristina |
|
2011 |
31 |
5 |
p. 466-471 6 p. |
artikel |
14 |
Uric Acid as a Mediator of Diabetic Nephropathy
|
Jalal, Diana I. |
|
2011 |
31 |
5 |
p. 459-465 7 p. |
artikel |
15 |
Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options
|
Doehner, Wolfram |
|
2011 |
31 |
5 |
p. 433-440 8 p. |
artikel |